Cingulate Inc (CING)
4.575
-0.08
(-1.61%)
USD |
NASDAQ |
Nov 22, 13:37
Cingulate Total Liabilities (Quarterly): 1.542M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.542M |
| June 30, 2024 | 2.043M |
| March 31, 2024 | 2.278M |
| December 31, 2023 | 10.36M |
| September 30, 2023 | 5.967M |
| June 30, 2023 | 11.33M |
| March 31, 2023 | 7.081M |
| December 31, 2022 | 7.523M |
| Date | Value |
|---|---|
| September 30, 2022 | 7.010M |
| June 30, 2022 | 1.619M |
| March 31, 2022 | 2.414M |
| December 31, 2021 | 2.043M |
| September 30, 2021 | 6.003M |
| June 30, 2021 | 4.793M |
| December 31, 2020 | 4.495M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.542M
Minimum
Sep 2024
11.33M
Maximum
Jun 2023
5.100M
Average
4.793M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| United Therapeutics Corp | 1.022B |
| Tonix Pharmaceuticals Holding Corp | 20.78M |
| Geovax Labs Inc | 2.608M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.58M |
| Shareholders Equity (Quarterly) | 12.04M |